Predictors of Treatment Response to Capsaicin Patch
Author:
Afonso Ancor Serrano
Reference31 articles.
1. Dworkin RH, O’Connor AB, Audette J, Baron R, Gourlay GK, Haanpää M, Kent JL, Krane EJ, LeBel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raja SN, Rice ASC, Schmader KE, Stacy B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clinic Proceedings. 2010;85(3 (Suppl.)):S3-S14. DOI: 10.4065/mcp.2009.0649 2. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. (2013) Efficacy of Qutenza (capsaicin) 8% patch for neuropathic pain: A 4 meta-analysis of the Qutenza clinical trials database. Pain. 2013;154:1632-1639. DOI: 10.1016/j.pain.2013.04.044. Epub 2013 May 21 3. Backonja MM. High-concentration capsaicin for the treatment of postherpetic neuralgia and other types of peripheral neuropathic pain. European Journal of Pain Supplements. 2010;4(S1):170-174. DOI: 10.1016/S1754-3207(10)70529-0 4. Backonja MM, Malan TP, Vanhove GF, Tobias JK. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomised, double-blind, controlled study with an open-label extension. Pain Medicine. 2010;11:600-608. DOI: 10.1111/j.1526-4637.2009.00793.x Epub 2010 Jan 22 5. Irving GA, Backonja MM, Dunteman E, Blonsky ER, Vanhove GF, Lu SP, Tobias J. NGX-4010 C117 study group. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Medicine. 2011 Jan;12(1):99-109. DOI: 10.1111/j.1526-4637.2010.01004.x Epub 2010 Nov 18
|
|